CureSight and EyeSwiftPro of NovaSight have been granted with the CE mark approval.

 

We are very happy to announce that our eye tracking based digital eye care solutions, CureSight, our treatment system for amblyopia, and EyeSwiftPro, our visual assesment system, have been granted with the CE mark approval.

The CE marking confirms that both devices meet the requirements of the Medical Devices Regulation (EU) 2017/745 Of The European Parliament And Of The Council (MDR), which now allows us to commercialize CureSight and the new EyeSwiftPro across the European Union and other CE Mark geographies.

This milestone brings us one step closer to our goal of providing digital eye care solutions for children.

 

Thank you to all the teams involved!